SPONSOR
Beijing Daxiang Biotech Co., Ltd
Total Trials
1
Recruiting
1
Phases
N/A
Conditions studied: Pancreatic Ductal Adenocarcinoma (PDAC)
Beijing Daxiang Biotech Co., Ltd is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Pancreatic Ductal Adenocarcinoma (PDAC).
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Daxiang Biotech Co., Ltd
How many clinical trials has Beijing Daxiang Biotech Co., Ltd sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Beijing Daxiang Biotech Co., Ltd, of which 1 are actively recruiting participants. These trials cover conditions including Pancreatic Ductal Adenocarcinoma (PDAC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Daxiang Biotech Co., Ltd research focus on?
Beijing Daxiang Biotech Co., Ltd clinical trials span Pancreatic Ductal Adenocarcinoma (PDAC). Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Beijing Daxiang Biotech Co., Ltd clinical trial?
To participate in a Beijing Daxiang Biotech Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Daxiang Biotech Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Beijing Daxiang Biotech Co., Ltd
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology